Science Applications International Corp (SAIC) stock
Close on Nov 17, 2026Market cap $6.06BP/E –Yield 1.02%
Earnings
Science Applications International's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.
Quarterly results
Revenue and earnings per share from each of Science Applications International's earnings releases, newest first
| Quarter | Reported | Revenue | YoY | EPS | Adj. EPS | Source |
|---|---|---|---|---|---|---|
| Q3 FY2027ended Oct 31, 2026 | Dec 3, 2026Expected | – | – | – | – | – |
| Q2 FY2027ended Jul 31, 2026 | Aug 31, 2026before the open | $1.88B | +6.2% | $2.38 | $3.01 | Release |
| Q1 FY2027ended May 1, 2026 | Jun 1, 2026before the open | $1.91B | +1.6% | $2.61 | $3.23 | Release |
| Q4 FY2026ended Jan 30, 2026 | Mar 16, 2026before the open | $1.75B | -4.9% | $1.87 | $2.62 | Release |
| Q3 FY2026ended Oct 31, 2025 | Dec 4, 2025before the open | $1.87B | -5.6% | $1.69 | $2.58 | Release |
| Q2 FY2026ended Aug 1, 2025 | Sep 4, 2025before the open | $1.77B | -2.7% | $2.71 | $3.63 | Release |
| Q1 FY2026ended May 2, 2025 | Jun 2, 2025before the open | $1.88B | +1.6% | $1.42 | $1.92 | Release |
| Q4 FY2025ended Jan 31, 2025 | Mar 17, 2025before the open | $1.84B | +5.7% | $2.00 | $2.57 | Release |
| Q3 FY2025ended Nov 1, 2024 | Dec 5, 2024before the open | $1.98B | +4.2% | $2.13 | $2.61 | Release |
| Q2 FY2025ended Aug 2, 2024 | Sep 5, 2024before the open | $1.82B | +2.2% | $1.58 | $2.05 | Release |
| Q1 FY2025ended May 3, 2024 | Jun 3, 2024before the open | $1.85B | -8.9% | $1.48 | $1.92 | Release |
| Q4 FY2024ended Feb 2, 2024 | Mar 18, 2024before the open | $1.74B | -11.7% | $0.74 | $1.43 | Release |
| Q3 FY2024ended Nov 3, 2023 | Dec 4, 2023before the open | $1.90B | -0.5% | $1.76 | $2.27 | Release |
| Q2 FY2024ended Aug 4, 2023 | Sep 7, 2023before the open | $1.78B | -2.7% | $4.56 | $2.05 | Release |
| Q1 FY2024ended May 5, 2023 | Jun 5, 2023before the open | $2.03B | +1.5% | $1.79 | $2.14 | Release |
| Q4 FY2023ended Feb 3, 2023 | Apr 3, 2023before the open | $1.97B | +9.4% | $1.34 | $2.04 | Release |
| Q3 FY2023ended Oct 28, 2022 | Dec 5, 2022before the open | $1.91B | +0.5% | $1.45 | $1.90 | Release |
| Q2 FY2023ended Jul 29, 2022 | Sep 1, 2022before the open | $1.83B | – | $1.30 | $1.75 | Release |
| Q1 FY2023ended Apr 29, 2022 | Jun 6, 2022before the open | $2.00B | – | $1.29 | $1.88 | Release |
| Q4 FY2022ended Jan 28, 2022 | Mar 28, 2022before the open | $1.80B | – | $0.76 | $1.50 | Release |
| Q3 FY2022ended Oct 29, 2021 | Dec 6, 2021before the open | $1.90B | – | $1.22 | $1.85 | Release |
| Q2 FY2022ended Jul 30, 2021 | Sep 2, 2021after the close | – | – | – | – | Release |
| Q1 FY2022ended Apr 30, 2021 | Jun 3, 2021after the close | – | – | – | – | Release |
| Q4 FY2021ended Jan 29, 2021 | Mar 25, 2021after the close | – | – | – | – | Release |
| Q3 FY2021ended Oct 30, 2020 | Dec 3, 2020after the close | – | – | – | – | Release |
| Q2 FY2021ended Jul 31, 2020 | Sep 2, 2020after the close | – | – | – | – | Release |
Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.
Current guidance
Science Applications International's latest outlook for periods it has not reported yet, compared with what it said before
| Metric | Period | Guidance | Before | Change | Given |
|---|---|---|---|---|---|
| Revenue | FY2027 | $7.20B – $7.30B | – | New | Aug 31, 2026 |
| RevenueGAAP | FY2027 | $7.00B – $7.20B | – | New | Mar 16, 2026 |
| RevenueGAAP | FY2027 | $7.00B – $7.20B | – | New | Feb 11, 2026 |
| Adjusted EBITDA Margin %non-GAAP | FY2027 | 10.3% – 10.5% | – | New | Aug 31, 2026 |
| Adjusted EBITDAnon-GAAP | FY2027 | $750.00M – $755.00M | $705.00M – $715.00M | Raised | Aug 31, 2026 |
| Adjusted EBITDAnon-GAAP | FY2027 | $705.00M – $715.00M | – | New | Mar 16, 2026 |
| Adjusted Diluted EPSnon-GAAP | FY2027 | $10.65 – $10.75 | – | New | Aug 31, 2026 |
| Adjusted Diluted EPSnon-GAAP | FY2027 | $9.50 – $9.70 | – | New | Mar 16, 2026 |
| Free Cash Flownon-GAAP | FY2027 | $600.00M | $600.00M | Reaffirmed | Aug 31, 2026 |
| Free Cash Flownon-GAAP | FY2027 | $600.00M | – | New | Mar 16, 2026 |
| Expenditures for property, plant, and equipment | FY2027 | $35.00M | – | New | Aug 31, 2026 |
| Expenditures for property, plant, and equipmentGAAP | FY2027 | $35.00M | – | New | Mar 16, 2026 |
| Adjusted EBITDA Margin %non-GAAP | FY2027 | 9.9% – 10.1% | – | New | Mar 16, 2026 |
| Adjusted EBITDA Margin % (1)non-GAAP | FY2027 | 9.9% – 10.1% | – | New | Feb 11, 2026 |
| Net cash provided by operating activitiesGAAP | FY2027 | $635.00M | – | New | Aug 31, 2026 |
| Net cash provided by operating activitiesGAAP | FY2027 | $635.00M | – | New | Mar 16, 2026 |
| Organic Growthnon-GAAP | FY2027 | -2% – 0% | -4% – -2% | Raised | Aug 31, 2026 |
| Organic Growthnon-GAAP | FY2027 | -4% – -2% | – | New | Mar 16, 2026 |
Guidance vs results
The last range Science Applications International gave before each report, against the figure it then reported. Full years add up the four quarters.
| Period | Metric | Guidance | Actual | Result |
|---|---|---|---|---|
| FY2026 | Adjusted Diluted EPS (1) | $9.80 – $10.00 | $10.75Σ4Q | Above range |
| FY2026 | Revenue | $7.28B – $7.33B | $7.27BΣ4Q | Below range |
| FY2025 | Adjusted Diluted EPS (1) | $8.50 – $8.65 | $9.15Σ4Q | Above range |
| FY2025 | Revenue | $7.43B – $7.48B | $7.49BΣ4Q | Above range |
Guidance history
Every forecast Science Applications International put in an earnings release, newest first
| Given | Metric | Period | Guidance | Change |
|---|---|---|---|---|
| Aug 31, 2026 | Expenditures for property, plant, and equipment | FY2027 | $35.00M | New |
| Aug 31, 2026 | Adjusted EBITDA | FY2027 | $750.00M – $755.00M | Raised |
| Aug 31, 2026 | Adjusted Diluted EPS | FY2027 | $10.65 – $10.75 | New |
| Aug 31, 2026 | Free Cash Flow | FY2027 | $600.00M | Reaffirmed |
| Aug 31, 2026 | Adjusted EBITDA Margin % | FY2027 | 10.3% – 10.5% | New |
| Aug 31, 2026 | Organic Growth | FY2027 | -2% – 0% | Raised |
| Aug 31, 2026 | Net cash provided by operating activities | FY2027 | $635.00M | New |
| Aug 31, 2026 | Revenue | FY2027 | $7.20B – $7.30B | New |
| Mar 16, 2026 | Expenditures for property, plant, and equipment | FY2027 | $35.00M | New |
| Mar 16, 2026 | Adjusted EBITDA | FY2027 | $705.00M – $715.00M | New |
| Mar 16, 2026 | Adjusted Diluted EPS | FY2027 | $9.50 – $9.70 | New |
| Mar 16, 2026 | Free Cash Flow | FY2027 | $600.00M | New |
| Mar 16, 2026 | Adjusted EBITDA Margin % | FY2027 | 9.9% – 10.1% | New |
| Mar 16, 2026 | Net cash provided by operating activities | FY2027 | $635.00M | New |
| Mar 16, 2026 | Organic Growth | FY2027 | -4% – -2% | New |
| Mar 16, 2026 | Revenue | FY2027 | $7.00B – $7.20B | New |
| Feb 11, 2026 | Adjusted EBITDA (1) | FY2027 | $705.00M – $715.00M | New |
| Feb 11, 2026 | Free Cash Flow (1) | FY2027 | $600.00M | New |
| Feb 11, 2026 | Organic Growth | FY2027 | -4% – -2% | New |
| Feb 11, 2026 | Adjusted EBITDA Margin % (1) | FY2027 | 9.9% – 10.1% | New |
| Feb 11, 2026 | Revenue | FY2027 | $7.00B – $7.20B | New |
| Dec 4, 2025 | Expenditures for property, plant, and equipment | FY2026 | $35.00M | Reaffirmed |
| Dec 4, 2025 | Adjusted EBITDA (1) | FY2026 | $695.00M | Raised |
| Dec 4, 2025 | Adjusted Diluted EPS (1) | FY2026 | $9.80 – $10.00 | Raised |
| Dec 4, 2025 | Free Cash Flow (1) | FY2026 | $550.00M | Reaffirmed |
| Dec 4, 2025 | Net cash provided by operating activities | FY2026 | $585.00M | Reaffirmed |
| Dec 4, 2025 | Adjusted EBITDA Margin % (1) | FY2026 | 9.5% | Raised |
| Dec 4, 2025 | Revenue | FY2026 | $7.28B – $7.33B | Raised |
| Sep 4, 2025 | Expenditures for property, plant, and equipment | FY2026 | $35.00M | Reaffirmed |
| Sep 4, 2025 | Adjusted EBITDA (1) | FY2026 | $680.00M – $690.00M | Lowered |
| Sep 4, 2025 | Adjusted Diluted EPS (1) | FY2026 | $9.40 – $9.60 | Raised |
| Sep 4, 2025 | Free Cash Flow (1) | FY2026 | $550.00M | Raised |
| Sep 4, 2025 | Adjusted EBITDA Margin % (1) | FY2026 | 9.3% – 9.5% | Lowered |
| Sep 4, 2025 | Net cash provided by operating activities | FY2026 | $585.00M | Raised |
| Sep 4, 2025 | Revenue | FY2026 | $7.25B – $7.33B | Lowered |
| Jun 2, 2025 | Expenditures for property, plant, and equipment | FY2026 | $35.00M | Reaffirmed |
| Jun 2, 2025 | Adjusted EBITDA (1) | FY2026 | $715.00M – $735.00M | Reaffirmed |
| Jun 2, 2025 | Adjusted Diluted EPS (1) | FY2026 | $9.10 – $9.30 | Reaffirmed |
| Jun 2, 2025 | Free cash flow (1) | FY2026 | $510.00M – $530.00M | Reaffirmed |
| Jun 2, 2025 | Net cash provided by operating activities | FY2026 | $545.00M – $565.00M | Reaffirmed |
| Jun 2, 2025 | Adjusted EBITDA Margin % (1) | FY2026 | 9.4% – 9.6% | New |
| Jun 2, 2025 | Revenue | FY2026 | $7.60B – $7.75B | Reaffirmed |
| Mar 17, 2025 | Expenditures for property, plant, and equipment | FY2026 | $35.00M | New |
| Mar 17, 2025 | Adjusted EBITDA (1) | FY2026 | $715.00M – $735.00M | New |
| Mar 17, 2025 | Adjusted Diluted EPS (1) | FY2026 | $9.10 – $9.30 | New |
| Mar 17, 2025 | Free Cash Flow (1) | FY2026 | $510.00M – $530.00M | New |
| Mar 17, 2025 | Adjusted EBITDA Margin % (1) | FY2026 | 9.4% – 9.6% | New |
| Mar 17, 2025 | Net cash provided by operating activities | FY2026 | $545.00M – $565.00M | New |
| Mar 17, 2025 | Revenue | FY2026 | $7.60B – $7.75B | New |
| Dec 5, 2024 | Expenditures for property, plant, and equipment | FY2025 | $30.00M | New |
| Dec 5, 2024 | Adjusted EBITDA (1) | FY2025 | $685.00M – $695.00M | New |
| Dec 5, 2024 | Adjusted Diluted EPS (1) | FY2025 | $8.50 – $8.65 | New |
| Dec 5, 2024 | Free Cash Flow (1) | FY2025 | $490.00M – $510.00M | New |
| Dec 5, 2024 | Net cash provided by operating activities | FY2025 | $520.00M – $540.00M | New |
| Dec 5, 2024 | Adjusted EBITDA Margin (1) | FY2025 | 9.3% | New |
| Dec 5, 2024 | Revenue | FY2025 | $7.43B – $7.48B | New |
| Sep 5, 2024 | Adjusted EBITDA (1) | FY2025 | $680.00M – $700.00M | Reaffirmed |
| Sep 5, 2024 | Adjusted Diluted EPS (1) | FY2025 | $8.10 – $8.30 | Raised |
| Sep 5, 2024 | Free Cash Flow (1) | FY2025 | $490.00M – $510.00M | Reaffirmed |
| Sep 5, 2024 | Adjusted EBITDA Margin (1) | FY2025 | 9.2% – 9.4% | Reaffirmed |
| Sep 5, 2024 | Revenue | FY2025 | $7.35B – $7.50B | Reaffirmed |
| Jun 3, 2024 | Expenditures for property, plant, and equipment | FY2025 | $30.00M | Reaffirmed |
| Jun 3, 2024 | Adjusted EBITDA (1) | FY2025 | $680.00M – $700.00M | Reaffirmed |
| Jun 3, 2024 | Adjusted Diluted EPS (1) | FY2025 | $8.00 – $8.20 | Reaffirmed |
| Jun 3, 2024 | Free Cash Flow (1) | FY2025 | $490.00M – $510.00M | Reaffirmed |
| Jun 3, 2024 | Adjusted EBITDA Margin (1) | FY2025 | 9.2% – 9.4% | Reaffirmed |
| Jun 3, 2024 | Net cash provided by operating activities | FY2025 | $520.00M – $540.00M | Reaffirmed |
| Jun 3, 2024 | Revenue | FY2025 | $7.35B – $7.50B | Reaffirmed |
| Mar 18, 2024 | Expenditures for property, plant, and equipment | FY2025 | $30.00M | New |
| Mar 18, 2024 | Adjusted EBITDA | FY2025 | $680.00M – $700.00M | New |
| Mar 18, 2024 | Adjusted Diluted EPS | FY2025 | $8.00 – $8.20 | New |
| Mar 18, 2024 | Free Cash Flow | FY2025 | $490.00M – $510.00M | New |
| Mar 18, 2024 | Net cash provided by operating activities | FY2025 | $520.00M – $540.00M | New |
| Mar 18, 2024 | Adjusted EBITDA Margin % | FY2025 | 9.2% – 9.4% | New |
| Mar 18, 2024 | Revenue | FY2025 | $7.35B – $7.50B | New |
| Dec 4, 2023 | Adjusted EBITDA Margin | FY2024 | 9.3% – 9.4% | Reaffirmed |
| Dec 4, 2023 | Adjusted Diluted EPS | FY2024 | $7.70 – $7.90 | Raised |
| Dec 4, 2023 | Transaction-Adjusted Free Cash Flow | FY2024 | $460.00M – $480.00M | Reaffirmed |
| Dec 4, 2023 | Revenue | FY2024 | $7.33B – $7.35B | Raised |
| Sep 7, 2023 | Adjusted EBITDA Margin | FY2024 | 9.3% – 9.4% | Raised |
| Sep 7, 2023 | Adjusted Diluted EPS | FY2024 | $7.20 – $7.40 | Raised |
| Sep 7, 2023 | Transaction-Adjusted Free Cash Flow | FY2024 | $460.00M – $480.00M | Reaffirmed |
| Sep 7, 2023 | Revenue | FY2024 | $7.20B – $7.25B | Raised |
| Jun 5, 2023 | Adjusted EBITDA Margin | FY2024 | 9.2% – 9.4% | Reaffirmed |
| Jun 5, 2023 | Adjusted Diluted EPS | FY2024 | $7.00 – $7.20 | Raised |
| Jun 5, 2023 | Transaction-Adjusted Free Cash Flow | FY2024 | $460.00M – $480.00M | Reaffirmed |
| Jun 5, 2023 | Revenue | FY2024 | $7.13B – $7.23B | Raised |
| Apr 3, 2023 | Expenditures for property, plant, and equipment | FY2024 | $30.00M | New |
| Apr 3, 2023 | Adjusted EBITDA Margin | FY2024 | 9.2% – 9.4% | New |
| Apr 3, 2023 | Adjusted Diluted EPS | FY2024 | $6.80 – $7.00 | New |
| Apr 3, 2023 | Free Cash Flow | FY2024 | $460.00M – $480.00M | New |
| Apr 3, 2023 | Net cash provided by operating activities | FY2024 | $490.00M – $510.00M | New |
| Apr 3, 2023 | Revenue | FY2024 | $7.05B – $7.20B | New |
| Dec 5, 2022 | Expenditures for property, plant, and equipment | FY2023 | $35.00M | Reaffirmed |
| Dec 5, 2022 | Adjusted EBITDA Margin (1) | FY2023 | 8.9% | Reaffirmed |
| Dec 5, 2022 | Adjusted Diluted EPS (1) | FY2023 | $7.05 – $7.20 | Raised |
| Dec 5, 2022 | Free Cash Flow (1) | FY2023 | $500.00M – $520.00M | Lowered |
| Dec 5, 2022 | Net cash provided by operating activities | FY2023 | $535.00M – $555.00M | Lowered |
| Dec 5, 2022 | Revenue | FY2023 | $7.60B | Raised |
| Sep 1, 2022 | Expenditures for property, plant, and equipment | FY2023 | $35.00M | Reaffirmed |
| Sep 1, 2022 | Adjusted EBITDA Margin | FY2023 | 8.9% | Reaffirmed |
| Sep 1, 2022 | Adjusted Diluted EPS | FY2023 | $7.00 – $7.20 | Raised |
| Sep 1, 2022 | Free Cash Flow | FY2023 | $500.00M – $530.00M | Reaffirmed |
| Sep 1, 2022 | Net cash provided by operating activities | FY2023 | $535.00M – $565.00M | Reaffirmed |
| Sep 1, 2022 | Revenue | FY2023 | $7.50B – $7.55B | Raised |
| Jun 6, 2022 | Adjusted EBITDA Margin | FY2023 | 8.9% | Reaffirmed |
| Jun 6, 2022 | Adjusted Diluted EPS | FY2023 | $6.90 – $7.20 | Raised |
| Jun 6, 2022 | Free Cash Flow | FY2023 | $500.00M – $530.00M | Reaffirmed |
| Jun 6, 2022 | Revenue | FY2023 | $7.43B – $7.55B | New |
| Mar 28, 2022 | Expenditures for property, plant, and equipment | FY2023 | $35.00M | New |
| Mar 28, 2022 | Adjusted EBITDA Margin | FY2023 | 8.9% | New |
| Mar 28, 2022 | Adjusted Diluted EPS | FY2023 | $6.80 – $7.10 | New |
| Mar 28, 2022 | Free Cash Flow | FY2023 | $500.00M – $530.00M | New |
| Mar 28, 2022 | Net cash provided by operating activities | FY2023 | $535.00M – $565.00M | New |
| Mar 28, 2022 | Revenue | FY2023 | $7.35B – $7.55B | New |
| Dec 6, 2021 | Adjusted EBITDA Margin (1) | FY2022 | 9% – 9.1% | New |
| Dec 6, 2021 | Adjusted Diluted EPS (1) | FY2022 | $6.75 – $6.95 | New |
| Dec 6, 2021 | Free Cash Flow (1) | FY2022 | $450.00M – $470.00M | New |
| Dec 6, 2021 | Revenue | FY2022 | $7.35B – $7.40B | New |
Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.
Press releases
Releases Science Applications International filed with the SEC as exhibits to Form 8-K or 6-K
- News
- News
- Update
- Results
- News
- Results
- News
- Results
- News
- Update
- Results
- Results
- Results
- Update
- Update
See a number that looks wrong?